Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XYF
3376
X Financial
XYF
$190M
| $365K | ﹤0.01% |
132,375
-2,700
| -2% | -$8.04K |
|
|
SWI
3377
DELISTED
SolarWinds Corporation Common Stock
SWI
| $365K | ﹤0.01% |
27,398
-129,200
| -83% | -$1.7M |
|
3378
Caleres
CAL
$431M
| $363K | ﹤0.01% |
+18,800
| New | +$408K |
|
|
DSEY
3379
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $363K | ﹤0.01% |
+48,000
| New | +$484K |
|
3380
Taylor Devices
TAYD
$165M
| $362K | ﹤0.01% |
36,562
-17,700
| -33% | -$181K |
|
3381
Consensus Cloud Solutions
CCSI
$670M
| $361K | ﹤0.01% |
6,000
-2,815
| -32% | -$163K |
|
3382
KALA BIO
KALA
$14.1M
| $361K | ﹤0.01% |
105
+55
| +110% | +$144K |
|
3383
Brink's
BCO
$4.88B
| $360K | ﹤0.01% |
+5,300
| New | +$363K |
|
3384
MakeMyTrip
MMYT
$5.36B
| $360K | ﹤0.01% |
+13,400
| New | +$345K |
|
3385
iShares US Regional Banks ETF
IAT
$674M
| $359K | ﹤0.01% |
+6,100
| New | +$386K |
|
3386
BancFirst
BANF
$3.79B
| $358K | ﹤0.01% |
+4,300
| New | +$334K |
|
|
KLRS
3387
Kalaris Therapeutics
KLRS
$83.5M
| $358K | ﹤0.01% |
+2,309
| New | +$461K |
|
3388
DarioHealth
DRIO
$70.9M
| $357K | ﹤0.01% |
+3,055
| New | +$505K |
|
3389
Enlivex Ltd
ENLV
$35.2M
| $356K | ﹤0.01% |
4,246
-267
| -6% | -$21.6K |
|
3390
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
| $355K | ﹤0.01% |
4,600
-4,300
| -48% | -$332K |
|
|
SISI
3391
DELISTED
Shineco
SISI
| $353K | ﹤0.01% |
11
-1
| -8% | -$42.7K |
|
|
CMCT
3392
Creative Media & Community Trust
CMCT
$10.3M
| $352K | ﹤0.01% |
2
+1
| +100% | +$188K |
|
|
SSBK
3393
DELISTED
Southern States Bancshares
SSBK
| $352K | ﹤0.01% |
+15,276
| New | +$322K |
|
|
BKSC
3394
DELISTED
Bank of South Carolina
BKSC
| $352K | ﹤0.01% |
18,881
+3,611
| +24% | +$71.8K |
|
3395
Acadia Pharmaceuticals
ACAD
$4.43B
| $351K | ﹤0.01% |
+14,500
| New | +$351K |
|
3396
Invesco CEF Income Composite ETF
PCEF
$801M
| $351K | ﹤0.01% |
15,900
-4,400
| -22% | -$98.5K |
|
3397
Honeywell
HON
$77B
| $350K | ﹤0.01% |
1,910
-579,412
| -100% | -$107M |
|
3398
iShares Core S&P US Value ETF
IUSV
$27.2B
| $349K | ﹤0.01% |
4,600
-23,000
| -83% | -$1.72M |
|
3399
Spyre Therapeutics
SYRE
$8.54B
| $349K | ﹤0.01% |
6,075
-3,853
| -39% | -$324K |
|
3400
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
| $348K | ﹤0.01% |
+7,600
| New | +$346K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.